Items where authors include "van Hout, B."

Article

Schneider, P. orcid.org/0000-0003-3552-1087, Devlin, N. orcid.org/0000-0002-1561-5361, van Hout, B. et al. (1 more author) (2024) Exploring health preference heterogeneity in the UK: Using the online elicitation of personal utility functions approach to construct EQ‐5D‐5L value functions on societal, group and individual level. Health Economics, 33 (5). pp. 894-910. ISSN 1057-9230

Devlin, N.J., Pan, T., Sculpher, M. et al. (5 more authors) (2023) Using age-specific values for pediatric HRQoL in cost-effectiveness analysis: is there a problem to be solved? If so, how? PharmacoEconomics, 41 (10). pp. 1165-1174. ISSN 1170-7690

Powell, P.A. orcid.org/0000-0003-1169-3431, Karimi, M., Rowen, D. et al. (3 more authors) (2023) Hypothetical versus experienced health state valuation: a qualitative study of adult general public views and preferences. Quality of Life Research, 32 (4). pp. 1187-1197. ISSN 0962-9343

Schneider, P. orcid.org/0000-0003-3552-1087, van Hout, B., Heisen, M. et al. (2 more authors) (2022) The online elicitation of personal utility functions (OPUF) tool: a new method for valuing health states [version 1; peer review: 1 approved]. Wellcome Open Research, 7. 14. ISSN 2398-502X

Landmesser, U., Lindgren, P., Hagström, E. et al. (7 more authors) (2022) Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden. European Heart Journal - Quality of Care and Clinical Outcomes, 8 (1). pp. 31-38. ISSN 2058-5225

Bunge, E.M., van Hout, B. orcid.org/0000-0001-9698-6094, Haas, S. et al. (2 more authors) (2021) Critical appraisal and issues regarding generalisability of comparative effectiveness studies of NOACs in atrial fibrillation and their relation to clinical trial data: a systematic review. BMJ Open, 11 (2). e042024. ISSN 2044-6055

Morrone, D., Kroep, S., Ricci, F. et al. (6 more authors) (2020) Mortality prediction of the CHA2DS2-VASc score, the HAS-BLED score, and their combination in anticoagulated patients with atrial fibrillation. Journal of Clinical Medicine, 9 (12). 3987.

van Hout, B. orcid.org/0000-0001-9698-6094, Hawe, E. and Cohen, A.T. (2020) Impact of patient characteristics on treatment outcomes in symptomatic venous thromboembolism: Results of HOKUSAI-VTE randomized trial analysis. TH Open, 04 (03). e245-e254. ISSN 2512-9465

van Hout, B. orcid.org/0000-0001-9698-6094, Mulhern, B., Feng, Y. et al. (2 more authors) (2020) The EQ-5D-5L value set for England : response to the “Quality Assurance”. Value in Health, 23 (5). pp. 649-655. ISSN 1098-3015

Bouwmeester, W., Briggs, A., van Hout, B. orcid.org/0000-0001-9698-6094 et al. (5 more authors) (2019) Methodology of a novel risk stratification algorithm for patients with multiple myeloma in the relapsed setting. Oncology and Therapy, 7 (2). pp. 141-157. ISSN 2366-1070

Chuang, L.-H., Gumbs, P., van Hout, B. et al. (9 more authors) (2019) Health-related quality of life and mortality in patients with pulmonary embolism: a prospective cohort study in seven European countries. Quality of Life Research, 28 (8). pp. 2111-2124. ISSN 0962-9343

Fonarow, G.C., van Hout, B. orcid.org/0000-0001-9698-6094, Villa, G. et al. (2 more authors) (2019) Updated cost-effectiveness analysis of evolocumab in patients with very high-risk atherosclerotic cardiovascular disease. JAMA Cardiology, 4 (7). pp. 691-695. ISSN 2380-6583

Devlin, N.J., Shah, K.K. orcid.org/0000-0002-4927-7858, Mulhern, B.J. et al. (2 more authors) (2019) A new method for valuing health: directly eliciting personal utility functions. European Journal of Health Economics, 20. pp. 257-270. ISSN 1618-7598

Stolk, E., Ludwig, K., Rand, K. et al. (2 more authors) (2019) Overview, update, and lessons learned From the international EQ-5D-5L valuation work: version 2 of the EQ-5D-5L valuation protocol. Value in Health, 22 (1). pp. 23-30. ISSN 1098-3015

Chuang, L.H., van Hout, B., Cohen, A.T. et al. (7 more authors) (2018) Deep-vein thrombosis in Europe — Burden of illness in relationship to healthcare resource utilization and return to work. Thrombosis Research, 170. pp. 165-174. ISSN 0049-3848

Willich, S.N., Chuang, L.-H., van Hout, B. et al. (7 more authors) (2018) Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to work. Thrombosis Research, 170. pp. 181-191. ISSN 0049-3848

Mulhern, B. orcid.org/0000-0003-3656-8063, Feng, Y., Shah, K. orcid.org/0000-0002-4927-7858 et al. (4 more authors) (2018) Comparing the UK EQ-5D-3L and English EQ-5D-5L value sets. PharmacoEconomics, 36 (6). pp. 699-713. ISSN 1170-7690

Feng, Y. orcid.org/0000-0003-4436-1126, Devlin, N.J. orcid.org/0000-0002-1561-5361, Shah, K.K. orcid.org/0000-0002-4927-7858 et al. (2 more authors) (2018) New methods for modelling EQ-5D-5L value sets: An application to English data. Health Economics, 27 (1). pp. 23-38. ISSN 1099-1050

Devlin, N.J. orcid.org/0000-0002-1561-5361, Shah, K.K. orcid.org/0000-0002-4927-7858, Feng, Y. orcid.org/0000-0003-4436-1126 et al. (2 more authors) (2018) Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Economics, 27 (1). pp. 7-22. ISSN 1057-9230

Rowen, D.L. orcid.org/0000-0003-3018-5109, Azzabi Zouraq, I., Chevrou-Severac, H. et al. (1 more author) (2017) International Regulations and Recommendations for Utility Data for Health Technology Assessment. PharmacoEconomics, 35 (Suppl 1). pp. 11-19. ISSN 1170-7690

Ara, R.M. orcid.org/0000-0002-7920-1707, Peasgood, T., Mukuria, C. et al. (7 more authors) (2017) Sourcing and Using Appropriate Health State Utility Values in Economic Models in Health Care. PharmacoEconomics, 35 (Suppl 1). pp. 7-9. ISSN 1170-7690

Fonarow, G.C., Keech, A.C., Pedersen, T.R. et al. (8 more authors) (2017) Cost-effectiveness of Evolocumab therapy for reducing cardiovascular events in patients with atherosclerotic cardiovascular disease. JAMA Cardiology, 2 (10). pp. 1069-1078. ISSN 2380-6583

Villa, G., Lothgren, M., Kutikova, L. et al. (7 more authors) (2017) Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain. Clinical Therapeutics, 39 (4). pp. 771-786. ISSN 0149-2918

Gandra, S.R., Villa, G., Fonarow, G.C. et al. (4 more authors) (2016) Cost-Effectiveness of LDL-C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States. Clinical Cardiology, 39 (6). pp. 313-320. ISSN 0160-9289

Krabbe, P.F.M., Devlin, N.J., Stolk, E.A. et al. (6 more authors) (2014) Multinational Evidence of the Applicability and Robustness of Discrete Choice Modeling for Deriving EQ-5D-5L Health-State Values. Medical Care, 52 (11). pp. 935-943. ISSN 0025-7079

Gu, N.Y., Botteman, M.F., Gerber, R.A. et al. (8 more authors) (2013) Eliciting health state utilities for Dupuytren's contracture using a discrete choice experiment. Acta Orthopaedica, 84 (6). pp. 571-578. ISSN 1745-3674

Gu, N.Y., Botteman, M.F., Ji, X. et al. (3 more authors) (2011) Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities. Health and Quality of Life Outcomes, 9. 119. ISSN 1477-7525

Treur, M., Heeg, B., Moller, H.J. et al. (2 more authors) (2009) A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss. BMC Health Services Research, 9. 32. ISSN 1472-6963

Monograph

Devlin, N., Shah, K.K., Feng, Y. et al. (2 more authors) (2016) Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England. Discussion Paper. HEDS Discussion Paper Series (16.02). Health Economics and Decision Science, School of Health and Related Research (ScHARR), University of Sheffield , Sheffield.

McHardy, J.P., van Hout, B. and Tsuchiya, A. (2015) Patent Purchase as a Policy for Pharmaceuticals. Working Paper. The Sheffield Economic Research Paper Series (SERPS) . Department of Economics, University of Sheffield ISSN 1749-8368

Ara, R., Kearns, B., Mukuria, C. et al. (2 more authors) (2013) Examining productivity losses associated with health related quality of life using patient and general population data. Project Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (8). Policy Research Unit in Economic Evaluation of Health and Care Interventions

Ara, R., van Hout, B., Kearns, B. et al. (1 more author) (2013) Case-mix methodology for the NHS outcomes framework GP Patient Survey Questionnaire Data. Project Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (008). Policy Research Unit in Economic Evaluation of Health and Care Interventions